TY - JOUR
T1 - Biological activities of sinularin
T2 - A literature-based review
AU - Islam, Muhammad Torequl
AU - Hossain, Rajib
AU - Hassan, Shardar Mohammad Hafiz
AU - Salehi, Bahare
AU - Martins, Natália
AU - Sharifi-Rad, Javad
AU - Amarowicz, Ryszard
N1 - Publisher Copyright:
Copyright: © 2020 by the C.M.B. Association. All rights reserved.
PY - 2020/6/25
Y1 - 2020/6/25
N2 - Sinularin ((9E)-13-hydroxy-4,9,13-trimethyl-17-methylidene-5,15-dioxatricyclo[12.3.1.0(4,6)] octadec-9-en-16-one) is the soft coral-derived hopeful biologically active lead compound. In this review sinularin biological activities are summarized. For that, an up-to-date (from 1980 to Mar 2020) search was made in the PubMed, Science Direct, Web of Science, Scopus, The American Chemical Society, Clinicaltrials.gov, and Google Scholar databases. Data available suggest that sinularin has interesting anti-inflammatory, anticancer, anti-fouling and analgesic potential. The inducible nitric oxide synthase (iNOS), cyclooxigenase (COX)-2, tumor growth factor beta 1 (TGF-β1) are the most efficient enzymes for interacting with sinularin due to its anti-inflammatory activity, while phosphoinositol 3-kinase (PI3K), Akt and mechanistic target of rapamycin (mTOR) for its anticancer effect. In conclusion, sinularin seems to be a promissory lead compound in the treatment of inflammation, cancer and neurological disorders.
AB - Sinularin ((9E)-13-hydroxy-4,9,13-trimethyl-17-methylidene-5,15-dioxatricyclo[12.3.1.0(4,6)] octadec-9-en-16-one) is the soft coral-derived hopeful biologically active lead compound. In this review sinularin biological activities are summarized. For that, an up-to-date (from 1980 to Mar 2020) search was made in the PubMed, Science Direct, Web of Science, Scopus, The American Chemical Society, Clinicaltrials.gov, and Google Scholar databases. Data available suggest that sinularin has interesting anti-inflammatory, anticancer, anti-fouling and analgesic potential. The inducible nitric oxide synthase (iNOS), cyclooxigenase (COX)-2, tumor growth factor beta 1 (TGF-β1) are the most efficient enzymes for interacting with sinularin due to its anti-inflammatory activity, while phosphoinositol 3-kinase (PI3K), Akt and mechanistic target of rapamycin (mTOR) for its anticancer effect. In conclusion, sinularin seems to be a promissory lead compound in the treatment of inflammation, cancer and neurological disorders.
KW - Cancer
KW - Inflammation
KW - Marine drugs
KW - Sinularin
UR - https://www.scopus.com/pages/publications/85087099813
U2 - 10.14715/cmb/2020.66.4.6
DO - 10.14715/cmb/2020.66.4.6
M3 - Artículo de revisión
C2 - 32583788
AN - SCOPUS:85087099813
SN - 0145-5680
VL - 66
SP - 33
EP - 36
JO - Cellular and Molecular Biology
JF - Cellular and Molecular Biology
IS - 4
ER -